Данные получены:
2024.
страница обновлена:
2025-11-05
В Филиппинах административный приказ Министерства здравоохранения от 2014 года (№0008) регулирует вопросы, связанные с электронными сигаретами. В этом документе электронные сигареты определяются как комбинация лекарственных средств и медицинских изделий, а не как табачные или потребительские товары, поэтому они подпадают под контроль Администрации по продуктам и лекарствам (FDA). Продажа и использование электронных сигарет разрешены законом. Новые правила, вступившие в силу с июля 2019 года, запрещают вейпинг в общественных местах. Министерство здравоохранения Филиппин выпустило административный приказ по электронным сигаретам 10 июля 2019 года, который начал действовать через 15 дней. Этот приказ распространяется только на электронные сигареты и не относится к стиковым табачным изделиям (ПНТ). Документ требует, чтобы компании, занимающиеся производством, импортом и розничной продажей электронных сигарет на территории Филиппин, получили лицензию на деятельность и зарегистрировали продукцию в течение трёх месяцев. Также предусмотрен запрет на любую форму рекламы, продвижения или спонсорства (более строгие правила, чем для сигарет), а также запрет на вкусовые добавки и компоненты, которые доказанно или предположительно могут привлекать молодежь.
1. Global Adult Tobacco Survey, 2015. Available at:https://nccd.cdc.gov/GTSSDataSurveyResources/Ancillary/DataReports.aspx?CAID=1
2. Calculation based on population size data of people over 15 years of age (16+). Source of population data: World Population Prospects 2019 [Internet]. United Nations; 2019. (Department of Economic and Social Affairs, editor. Population Division). Report No.: Rev. 1. Available from: https://population.un.org/wpp/Download/Standard/Population/
1. Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
2. Calculation based on population size data of people over 15 years of age (16+). Source of population data: World Population Prospects 2019 [Internet]. United Nations; 2019. (Department of Economic and Social Affairs, editor. Population Division). Report No.: Rev. 1. Available from: https://population.un.org/wpp/Download/Standard/Population/
Комментарии:
In Philippines, GATS was conducted in 2015 as a household survey of persons 15 years of age and older. A multi-stage, geographically clustered sample design was used to produce nationally representative data. There were a total of 11,644 completed individual interviews.
World Population Prospects 2019 [Internet]. United Nations; 2019. (Department of Economic and Social Affairs, editor. Population Division). Report No.: Rev. 1. Available from: https://population.un.org/wpp/Download/Standard/Population/
Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
Комментарии:
In Philippines, GATS was conducted in 2015 as a household survey of persons 15 years of age and older. A multi-stage, geographically clustered sample design was used to produce nationally representative data. There were a total of 11,644 completed individual interviews.
Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
In Philippines, GATS was conducted in 2015 as a household survey of persons 15 years of age and older. A multi-stage, geographically clustered sample design was used to produce nationally representative data. There were a total of 11,644 completed individual interviews.
Ссылки:
1. Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
2. Calculation based on population size data of people over 15 years of age (16+). Source of population data: World Population Prospects 2019 [Internet]. United Nations; 2019. (Department of Economic and Social Affairs, editor. Population Division). Report No.: Rev. 1. Available from: https://population.un.org/wpp/Download/Standard/Population/
Global Adult Tobacco Survey (GATS) 2021 cited in WHO. (2025). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 (6th edn). World Health Organization. https://www.who.int/publications/i/item/9789240116276
Data cross-referenced where possible using the following sources :1. Vapetrotter website. Available at: https://www.vapetrotter.com/laws/ ; 2. Global tobacco control website. Available at:https://www.globaltobaccocontrol.org/node/14052 ; 3. Tobacco Control Laws website. Available at : https://www.tobaccocontrollaws.org/legislation/
E-cigarettes, HTPs and novelty tobacco products, such as snus and nicotine pouches, are currently covered by RA 11900, where they are considered consumer products unless they contain medical claims - in which case they first require FDA approval. E-cigarettes, HTPs and novelty tobacco products, such as snus and nicotine pouches, are currently covered by RA 11900, where they are considered consumer products unless they contain medical claims - in which case they first require FDA approval.
E-cigarettes, HTPs and novelty tobacco products, such as snus and nicotine pouches, are currently covered by RA 11900, where they are considered consumer products unless they contain medical claims - in which case they first require FDA approval. E-cigarettes, HTPs and novelty tobacco products, such as snus and nicotine pouches, are currently covered by RA 11900, where they are considered consumer products unless they contain medical claims - in which case they first require FDA approval.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.